Cargando…
Downregulation of ITIH3 contributes to cisplatin-based chemotherapy resistance in ovarian carcinoma via the Bcl-2 mediated anti-apoptosis signaling pathway
Platinum resistance of ovarian cancer is one of the primary factors of poor prognosis and inter-α-trypsin inhibitor heavy chain 3 (ITIH3) is a potential DDP resistance-associated gene. The present study assessed protein expression levels of ITIH3 in human ovarian cancer and evaluated the relationshi...
Autores principales: | Liu, Yingzhao, Shi, Lijun, Yuan, Cunzhong, Feng, Yan, Li, Mengdi, Liu, Hongmei, Chen, Xi, Yao, Desheng, Wang, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827458/ https://www.ncbi.nlm.nih.gov/pubmed/36644154 http://dx.doi.org/10.3892/ol.2022.13646 |
Ejemplares similares
-
ITIH5, a p53-responsive gene, inhibits the growth and metastasis of melanoma cells by downregulating the transcriptional activity of KLF4
por: Liu, Jia, et al.
Publicado: (2021) -
ITIH5 mediates epigenetic reprogramming of breast cancer cells
por: Rose, Michael, et al.
Publicado: (2017) -
Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5
por: Young, Eric D., et al.
Publicado: (2020) -
BNIP3 contributes to cisplatin‐induced apoptosis in ovarian cancer cells
por: Jia, Jinghui, et al.
Publicado: (2020) -
ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism
por: Pihl, Rasmus, et al.
Publicado: (2021)